Spectral Medical Inc EDTXF:OTCPK

RT Quote | Exchange | USD
Last | 1:03 PM EST
0.5027quote price arrow down-0.0023 (-0.4554%)
Volume
30,985
52 week range
0.26 - 0.60

...

Loading . . .

KEY STATS

  • Open0.4972
  • Day High0.51
  • Day Low0.4841
  • Prev Close0.505
  • 52 Week High0.60
  • 52 Week High Date02/18/21
  • 52 Week Low0.26
  • 52 Week Low Date03/16/20
  • Market Cap119.02M
  • Shares Out236.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • 1 Year % Change2.59

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-18.35
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-6.469M
  • ROE (MRQ)-338.87%
  • Revenue (MRQ)1.81M
  • Gross Margin (MRQ)76.08%
  • Net Margin (MRQ)-361.81%
  • Debt To Equity (MRQ)50.89%

EVENTS

  • Earnings Date03/29/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Spectral Medical Inc News

There is no recent news for this security.

Latest EDTXF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Spectral Medical Inc. is a late stage theranostic company advancing therapeutic options for sepsis and septic shock. The Company has developed a product for the treatment of patients with septic shock, Toraymyxin (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA). The EAA is a rapid in-vitro diagnostic test that measures negative bacterial cell wall...
Anthony Bihl III
Chairman
Paul Walker M.D. Ph.D.
President
Chris Seto
Chief Financial Officer
Debra Foster
Vice President
Gualitiero Guadagni
Vice President
Address
135 - 2 The West Mall
Toronto, ON
M9C 1C2
Canada